A carregar...
P15.18 NAUSEA AND EMESIS DURING NEUROONCOLOGICAL CHEMOTHERAPY - PROBLEM RESOLVED WITH ANY SETRONE?
BACKGROUND: Temozolomide, the most important chemotherapeutic agent used in neurooncology, has moderate emetogenic potential. With the introduction of ondansetron, the first 5HT3-antagonist on the market, most of us neurooncologists thought that the problem of nausea and emesis was resolved. Some pa...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185657/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.297 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|